Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “immunotherapy”

175 pharma patents match "immunotherapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 175
Index total 30,257
Page 7 / 8

Quick answer

This filtered view shows 175 pharmaceutical patents matching "immunotherapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

175 results for “immunotherapy” · 30,257 patents in full index Clear search

  1. US 9399662

    Concurrent chemotherapy and immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  2. US 9375475

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  3. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  4. US 9290541

    TCL1 peptides for immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  5. US 9102752

    Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

    United Biomedical, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  6. US 8911722

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  7. US 8883500

    Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy

    Northwestern University · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted

  8. US 8815229

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  9. US 8734778

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted May 27, 2014 · Expires May 22, 2034

    granted

  10. US 8709417

    Combination immunotherapy for the treatment of cancer

    BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8597946

    Enhanced dendritic cells for cancer immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

  12. US 8546371

    Nanoparticle formulated glycolipid antigens for immunotherapy

    The Board of Regents of the University of Texas System · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  13. US 8338173

    Preparation of antigen-presenting human γδ T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  14. US 8337830

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  15. US 8287857

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  16. US 8153136

    Yeast-based vaccines as immunotherapy

    The Regents of the University of Colorado · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  17. US 8153426

    Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

    University College Cardiff Consultants Limited · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  18. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  19. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  20. US 7919079

    Cancer immunotherapy compositions and methods of use

    The Regents of the University of California · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  21. US 7713526

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted May 11, 2010 · Expires May 6, 2030

    granted

  22. US 7682607

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

  23. US 7449557

    Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

    University of Connecticut Health Center · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted

  24. US 7264820

    Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline

    The Regents of the University of California · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.